-
1601por Choi, Eun-Jin, Wu, Wenzhe, Zhang, Ke, Yuan, Xiaohong, Deng, Junfang, Ismail, Deena, Buck, Darby L., Thomason, Kerrie S., Garofalo, Roberto P., Zhang, Shenglong, Bao, Xiaoyong“…We previously reported that respiratory syncytial virus (RSV) infection induces functional tRFs, which are derived from a limited subset of parent tRNAs, in airway epithelial cells. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1602“…Respiratory syncytial virus (RSV) has a major role in respiratory infections in young infants around the world. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1603por Riccò, Matteo, Corrado, Silvia, Cerviere, Milena Pia, Ranzieri, Silvia, Marchesi, Federico“…Respiratory Syncytial Virus (RSV) is a leading cause of morbidity and hospitalization in all infants. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1604por Tovo, Pier-Angelo, Garazzino, Silvia, Savino, Francesco, Daprà, Valentina, Pruccoli, Giulia, Dini, Maddalena, Filisetti, Giacomo, Funiciello, Elisa, Galliano, Ilaria, Bergallo, Massimiliano“…Their expression in infants with respiratory syncytial virus (RSV) bronchiolitis is poorly defined. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1605“…Neither infection nor vaccination give long-lasting immunity and, here, in an attempt to understand why this might be, we have compared the neutralizing antibody responses to SARS-CoV-2 with those specific for human immunodeficiency virus type 1 (HIV-1) and respiratory syncytial virus (RSV). Currently, most of the antibodies specific for the SARS-CoV-2 S protein map to three broad antigenic sites, all at the distal end of the S trimer (receptor-binding site (RBD), sub-RBD and N-terminal domain), whereas the structurally similar HIV-1 and the RSV F envelope proteins have six antigenic sites. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1606por Shusterman, Eden, Kliuk Ben-Bassat, Orit, Zahler, David, Kupershmidt, Aviv, Weiss-Meilik, Ahuva, Kehat, Orli, Ablin, Jacob N.“…Nevertheless, other common respiratory viruses such as Influenza and Respiratory Syncytial Virus (RSV) are also associated with AKI. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1607“…We aimed to determine the prevalence of bacterial coinfection (CoBact) and bacterial superinfection (SuperBact), the causative pathogens, the initial antibiotic-prescribing practice, and the associated clinical outcomes of hospitalized patients with respiratory syncytial virus-associated acute respiratory illness (RSV-ARI). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1608por Ramirez, Julio, Carrico, Ruth, Wilde, Ashley, Junkins, Alan, Furmanek, Stephen, Chandler, Thomas, Schulz, Paul, Hubler, Robin, Peyrani, Paula, Liu, Qing, Trivedi, Sonali, Uppal, Sonal, Kalina, Warren V., Falsey, Ann R., Walsh, Edward E., Yacisin, Kari, Jodar, Luis, Gessner, Bradford D., Begier, Elizabeth“…INTRODUCTION: Nearly all existing respiratory syncytial virus (RSV) incidence estimates are based on real-time polymerase chain reaction (RT–PCR) testing of nasal or nasopharyngeal (NP) swabs. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1609“…BACKGROUND: Respiratory syncytial virus (RSV) infection of airway epithelial cells stimulates the expression and secretion of a variety of cytokines including the chemotactic cytokines interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1), and RANTES (regulated upon activation, normal T cell expressed and secreted). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1610por Mondì, Vito, Paolillo, Piermichele, Bedetta, Manuela, Lucangeli, Natalia, Picone, Simonetta“…BACKGROUND: Preterm infants born between 33 and 35 weeks of gestational age (wGA) have been considered a “major underserved population” and ineligible to receive palivizumab (PLV), the only drug authorized to date for respiratory syncytial virus (RSV) prophylaxis, by current international guidelines. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1611por Cong, Bingbing, Dighero, Izzie, Zhang, Tiantian, Chung, Alexandria, Nair, Harish, Li, YouEnlace del recurso
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1612por Bebia, Zourab, Reyes, Osvaldo, Jeanfreau, Robert, Kantele, Anu, De Leon, Ruth Graciela, Sánchez, Marta García, Banooni, Peyman, Gardener, Glenn J, Rasero, José Luis Bartha, Pardilla, Maria Begoña Encinas, Langley, Joanne M, Di Leo, Claudio Maañón, Botelho-Nevers, Elisabeth, Buttery, Jim, Laurichesse, Helene, Madhi, Shabir A, García, Adrián Martín, Stanley, Thorsten, Barjat, Tiphaine, Griffith, Rebecca, Castrejón-Alba, Maria Mercedes, de Heusch, Magali, Dieussaert, Ilse, Hercor, Melanie, Lese, Patricia, Qian, Hui, Tullio, Antonella N, Henry, Ouzama“…BACKGROUND: In a phase 1/2 study, a maternal respiratory syncytial virus vaccine candidate (RSVPreF3) demonstrated an acceptable safety profile and efficiently increased RSV-specific humoral immune responses in non-pregnant women. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1613por Lundeen, Kristin, Pfeiffenberger, Trista, Vann, Julie Jacobson, O’Brien, Timothy, Sampson, Charlene, Wegner, Steven“…Clinical criteria utilized by North Carolina (NC) Medicaid for use of palivizumab for respiratory syncytial virus (RSV) prophylaxis are consistent with the most recent guidelines published in the Red Book: Report of the Committee on Infectious Diseases. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1614“…Due to the pandemics in 2019, Human Respiratory Syncytial Virus and Coronavirus have attracted the attention of different kinds of research. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1615por Tian, Jiahua, Liu, Congyue, Wang, Xunling, Zhang, Ling, Zhong, Guoying, Huang, Guichuan, Wang, Hongping, Hu, Hao, Gong, Ling, Liu, Daishun“…BACKGROUND: Respiratory syncytial virus (RSV) infection in adults remains less recognized and understood, both socially and clinically, compared to influenza virus infection. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1616por Thampi, Nisha, Moggridge, Jason, Khov, Engluy, Hinz, Aaron, Castellani, Lucas, Doukhanine, Evgueni, Hug, Laura, Kassen, Rees, MacFadden, Derek, Nott, Caroline, Wong, Alex, Fralick, Michael“…BACKGROUND: Annual respiratory syncytial virus (RSV) epidemics disproportionately impact infants and young children. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1617por Branigan, Patrick J, Liu, Changbao, Day, Nicole D, Gutshall, Lester L, Sarisky, Robert T, Del Vecchio, Alfred M“…Human respiratory syncytial virus (HRSV) is an important respiratory pathogen primarily affecting infants, young children, transplant recipients and the elderly. …”
Publicado 2005
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1618por Huck, Barbara, Neumann-Haefelin, Dieter, Schmitt-Graeff, Annette, Weckmann, Markus, Mattes, Jörg, Ehl, Stephan, Falcone, Valeria“…BACKGROUND: Human metapneumovirus (HMPV) and respiratory syncytial virus (RSV) are members of the Pneumovirinae subfamily of Paramyxoviridae and can cause severe respiratory disease, especially in infants and young children. …”
Publicado 2007
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1619por Sparer, Tim E., Matthews, Stephen, Hussell, Tracy, Rae, Aaron J., Garcia-Barreno, Blanca, Melero, Jose A., Openshaw, Peter J.M.“…In a murine model of respiratory syncytial virus disease, prior sensitization to the attachment glycoprotein (G) leads to pulmonary eosinophilia and enhanced illness. …”
Publicado 1998
Enlace del recurso
Enlace del recurso
Texto -
1620por Jartti, Tuomas, Paul-Anttila, Maria, Lehtinen, Pasi, Parikka, Vilhelmiina, Vuorinen, Tytti, Simell, Olli, Ruuskanen, Olli“…The risk is more important than that associated with respiratory syncytial virus (RSV) disease. No comparative data are available on the immune responses of these diseases. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto